Remsleep Holdings

What Remsleep Holdings does

RemSleep Holdings, Inc. (OTCQB: RMSL) is a publicly traded US medical device company headquartered in Orlando, Florida, focused exclusively on the DeltaWave nasal pillow CPAP mask system for the treatment of obstructive, central, and complex sleep apnea as well as comorbid respiratory conditions including congestive heart failure, neuromuscular disease, and COPD. The DeltaWave is a miniaturized nasal pillow interface cleared by the FDA under 510(k) (initial clearance in 2025; expanded clearance K253939 in January 2026) for use with all non-invasive positive airway pressure devices — not just CPAP — across both home and institutional settings including hospitals, long-term care facilities, rehabilitation centers, and sleep laboratories.

The company operates a single-product, hardware-sales revenue model, commercializing DeltaWave through a direct sales network covering 48 states targeting institutional healthcare buyers alongside home-care CPAP channels. Pricing is not publicly disclosed and is quote-based. Early market signals include a 70-unit deployment by an early adopting provider with zero returns and repeat orders. Management is targeting 1,500–1,600 units per month as an initial sustainable volume benchmark and is publicly exploring capital-raising options to fund continued growth.

RemSleep is a microcap (approximately $12.8M valuation as of January 2026) with 11–50 employees, no disclosed institutional venture funding, and recent leadership transition: following the passing of founder/Chairman/CEO Thomas Wood in February 2026, Anita Michaels was appointed Chairman, Jeffrey Marshall became CEO, and Alexander Johnson joined as Director. The company reported 2025 revenue of $16,721 against an operating loss of approximately $2.77M, reflecting the pre-commercialization buildout phase that preceded the 2025–2026 FDA and sales infrastructure activation.

Name

Remsleep Holdings

Legal name

RemSleep Holdings, Inc.

Website

https://remsleep.com

Company type

Public

Founded year

2007

Operating status

Operating

Headcount range

11–50 employees

Short description

RemSleep Holdings is a US public microcap medical device company that designs and commercializes the FDA-cleared DeltaWave nasal pillow CPAP mask system for sleep apnea and respiratory treatment across home-care and institutional healthcare channels.

Ownership category

akta.pro rank

Product category

Sleep Apnea Treatment Devices

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)

SIC

Surgical & Medical Instruments & Apparatus (3841)

akta.pro industry

PRIMARYHLAHAGAA

Sleep Apnea Therapy Devices (CPAP/APAP/BiPAP/ASV)

Healthcare & Life Sciences/Medical Devices & Diagnostics/Respiratory & Sleep Therapy Devices

SECONDARYHSABAKAD

Respiratory & Sleep Therapy Equipment (Oxygen, CPAP/BiPAP, Nebulizers)

Home & Personal Services/Elder Care & In-Home Care Services/Medical Equipment & Home Mobility Support Services

Keywords

• CPAP mask systems
• Sleep apnea treatment
• Nasal pillow interface
• Respiratory medical devices
• Non-invasive ventilation

Headquarters

HQ city

Orlando

HQ country

United States

HQ region

North America

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Operations, Personnel, Marketing or Sales, Technology or R&D, Supply Chain, Infrastructure

Revenue model

1. DeltaWave CPAP Mask Hardware Sales: Primary revenue stream from sale of the FDA-cleared DeltaWave nasal pillow CPAP mask system. Early market signals indicate strong retention and repeat orders, with one early adopting provider reporting zero returns across a 70-unit deployment. Company targets 1,500-1,600 units per month as initial sustainable volume benchmark.

Pricing tiers

Go-to-market motion1 record

Distribution channels2 records

Marketing channels2 records

Core offering

RemSleep Holdings designs and manufactures the DeltaWave nasal pillow CPAP mask system, an FDA 510(k)-cleared (K253939) medical device for sleep apnea and related respiratory conditions. The product is sold to institutional healthcare providers (hospitals, long-term care, rehabilitation centers, sleep laboratories) and home-based CPAP therapy channels, and is cleared for use with all non-invasive positive airway devices across multiple patient populations.

Product overview

Remsleep Holdings is a single-product medical device company focused on its DeltaWave CPAP mask system. The DeltaWave is a nasal pillow CPAP mask cleared by the FDA for sleep apnea treatment. The company recently received expanded FDA 510(k) clearance in January 2026, extending use from home-based therapy to institutional settings and broadening the indicated patient population to include central sleep apnea, complex sleep apnea, congestive heart failure, neuromuscular diseases, and COPD. The company is transitioning from infrastructure buildout to active market execution, targeting 1,500-1,600 units per month as an initial sustainable volume benchmark.

Differentiator

Problem solved

Functional benefit

Brands

• DeltaWave: Nasal pillow CPAP mask system for sleep apnea treatment, cleared by FDA for home and institutional use.

Products and services

• DeltaWave nasal pillow CPAP mask system The DeltaWave nasal pillow CPAP mask system is the company's FDA 510(k)-cleared (K253939) medical device for non-invasive positive airway pressure therapy. It features a micro-sized nasal pillow interface and is intended for use with CPAP, BiPAP, and other non-invasive positive airway devices. The product is sold to institutional healthcare providers (hospitals, long-term care facilities, rehabilitation centers, sleep laboratories) and home-based CPAP therapy patients for the treatment of obstructive sleep apnea, central sleep apnea, complex sleep apnea, congestive heart failure, neuromuscular diseases, and COPD.

Quantifiable outcome

• Zero returns across 70-unit deployment with repeat orders

Named customers1 record

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature2 records

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• ResMed: Global market leader in sleep apnea and CPAP devices, with the broadest CPAP mask portfolio (AirFit, AirTouch) including nasal pillow lines. Directly comparable as a CPAP mask and sleep apnea therapy competitor; far larger and more diversified.
• Fisher & Paykel Healthcare: Leading manufacturer of nasal pillow CPAP masks (Brevida, F&P Nova) and a major player in hospital respiratory care. Directly comparable on nasal pillow design and on institutional/hospital respiratory product overlap.
• Drive DeVilbiss Healthcare: Broad-line respiratory and sleep therapy manufacturer producing CPAP/BiPAP devices and masks (including nasal pillow forms). Comparable through its CPAP product line and home/institutional distribution footprint.
• Philips Respironics: Major incumbent in CPAP masks, BiPAP, and hospital ventilation with the DreamWear nasal pillow line as a direct competitive product. Comparable across both home and institutional channels; significantly larger and currently navigating CPAP recall-related product transitions.

Direct peers

• Apex Medical: Designs and manufactures CPAP/BiPAP devices and masks, including nasal pillow interfaces used in both home and clinical sleep therapy. Closely comparable as a CPAP mask manufacturer operating in the same indications and channels.
• BMC Medical: Chinese medical device manufacturer with a global CPAP/BiPAP and mask line including nasal pillow products. Comparable as a competing CPAP mask brand targeting sleep apnea and respiratory conditions in home and institutional settings.
• 3B Medical: U.S. CPAP device and mask manufacturer focused on sleep apnea and respiratory care with both consumer and clinical channels. Comparable as a similarly-sized competitor in CPAP mask and device commercialization.
• Transcend / Somnetics International: Manufacturer of compact CPAP devices and compatible mask interfaces for sleep apnea therapy. Comparable as a smaller, single-category CPAP equipment competitor pursuing the home and travel therapy channel.

Emerging players

• Circadiance: Smaller specialty manufacturer of CPAP interfaces including nasal pillow and cloth-based mask systems. Comparable as a niche CPAP mask designer targeting sleep apnea patients with comfort/differentiation messaging.
• React Health (formerly 3B Medical / CPAP retail assets): Respiratory and sleep therapy provider offering CPAP masks, devices, and related supplies to home and clinical customers. Comparable as a mid-sized CPAP mask and equipment distributor/manufacturer operating in overlapping channels.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/remsleepinc

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds2 records

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Remsleep Holdings